Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis

Silvia Fargion, Clara Mandelli, Alberto Piperno, Bruno Cesana, Anna L. Fracanzani, Mirella Fraquelli, Paolo A. Bianchi, Gemino Fiorelli, Dario Conte – 1 April 1992 – Two hundred twelve Italian patients with genetic hemochromatosis (181 men, mean age 50 ± 11 yr; and 31 women, mean age 49 ± 10 yr) were followed for a median period of 44 mo (range = 3 to 218 mo). Alcohol abuse was present in 31 subjects (15%), and chronic HBV and HCV infection were seen in 19 (9%) and 35 (24%) of 145 cases tested, respectively. Twenty‐four patients (11%) had concomitant p‐thalassemia trait.

Hydroxypyridinium collagen cross‐links in human liver fibrosis: Study of alveolar echinococcosis

Sylvie Ricard‐Blum, Solange Bresson‐Hadni, Dominique‐Angèle Vuitton, Gerard Ville, Jean‐Alexis Grimaud – 1 April 1992 – Liver samples from patients with three different types of liver diseases, alveolar echinococcosis (a dense and irreversible fibrosis), hepatocellular carcinoma and alcoholic cirrhosis, were analyzed for their content in hydroxypyridinium cross‐links found in mature collagen. We demonstrated the presence of small amounts of pyridinoline in control livers (0.27 ± 0.06 pmol/pmol of collagen).

The pathology of hepatitis C

Peter J. Scheuer, Parvin Ashrafzadeh, Sheila Sherlock, David Brown, Geoffrey M. Dusheiko – 1 April 1992 – To determine the histologic pattern of hepatitis C, 54 liver biopsy specimens from 45 patients with a clinicopathological diagnosis of hepatitis C were studied. All patients were seropositive for antibody to hepatitis C virus by second‐generation testing. Both transfusion‐related and sporadic cases were included. More than half the samples showed chronic hepatitis without cirrhosis, whereas 44% showed developing or fully established cirrhosis.

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

Carla Colombo, Maria Rita Castellani, William F. Balistreri, Ettore Seregni, Maria Luisa Assaisso, Annamaria Giunta – 1 April 1992 – We have previously documented that ursodeoxycholic acid exerts a beneficial effect on liver function and bile acid metabolism in patients with cystic fibrosis. We hypothesized that the mechanism of action may be related in part to the choleretic properties of the administered bile acid.

Liver function in acute viral hepatitis as determined by a hepatocyte‐specific ligand: 99mTc‐galactosyl–neoglycoalbumin

Irene Virgolini, Christian Müller, Josef Höbart, Werner Scheithauer, Peter Angelberger, Helmar Bergmann, John O'Grady, Helmut Sinzinger – 1 April 1992 – Twelve patients with recently diagnosed acute viral hepatitis underwent serial 99mTc‐galactosyl neoglycoalbumin scanning of the liver (for up to 8 mo). Injection of 99mTc‐galactosyl neoglycoalbumin (150 mBq) at a rate of 3.5 mg (50 nmol; 1 ml) revealed that the liver is the exclusive site of tracer uptake.

Atrial natriuretic peptide in portal vein–ligated rats: Alterations in cardiac production, plasma level and glomerular receptor density and affinity

Gavin M. Jonas, Timothy R. Morgan, Kengathevy Morgan, Inthirany Thillainadarajah, Cynthia Hornacek – 1 April 1992 – The atrial natriuretic peptide hormonal system is altered to a variable degree in patients with cirrhosis. Portal pressure and portal‐systemic shunting are also varied in cirrhosis. We used a portal vein–ligated rat model with predictable portal hypertension to study the effects of portal hypertension alone on the atrial natriuretic peptide hormonal system. Sham‐operated rats were used as controls.

Interactions between human immunodeficiency virus‐1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus

Chantal Housset, Stanislas Pol, Françoise Carnot, Frédéric Dubois, Bertrand Nalpas, Bruno Housset, Pierre Berthelot, Christian Brechot – 1 April 1992 – To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, we retrospectively analyzed 260 patients, 146 of whom were followed for a mean of 31.4 ± 1.8 mo.

Subscribe to